ARIA-H (amyloid-related imaging abnormalities with microhemorrhages and hemosiderin deposits)

E125385

ARIA-H (amyloid-related imaging abnormalities with microhemorrhages and hemosiderin deposits) is a brain MRI finding characterized by small cerebral microbleeds and hemosiderin accumulation, typically associated with anti-amyloid therapies for Alzheimer’s disease.

All labels observed (1)

How this entity was disambiguated

Statements (50)

Predicate Object
instanceOf amyloid-related imaging abnormality ⓘ
radiologic finding ⓘ
abbreviationFor amyloid-related imaging abnormalities with microhemorrhages and hemosiderin deposits ⓘ
associatedWith Alzheimer's disease ⓘ
aducanumab ⓘ
linked to: Aduhelm

anti-amyloid therapy ⓘ
cerebral amyloid angiopathy ⓘ
donanemab ⓘ
linked to: Leqembi

lecanemab ⓘ
linked to: Leqembi

monoclonal antibodies targeting beta-amyloid ⓘ
canBeAsymptomatic true ⓘ
canCauseSymptom confusion ⓘ
focal neurological deficits ⓘ
headache ⓘ
seizures ⓘ
distinguishedFrom ARIA-E ⓘ
firstDescribedInContextOf clinical trials of anti-amyloid therapies for Alzheimer's disease ⓘ
fullName amyloid-related imaging abnormalities with microhemorrhages and hemosiderin deposits ⓘ
hasCourse may stabilize or progress with continued exposure to anti-amyloid therapy ⓘ
hasFeature cerebral microbleeds ⓘ
hemosiderin deposits ⓘ
lobar microhemorrhages ⓘ
punctate hypointense lesions on susceptibility-sensitive sequences ⓘ
superficial siderosis ⓘ
hasImagingModality magnetic resonance imaging ⓘ
hasLateralityPattern often multifocal and bilateral ⓘ
hasPathophysiology microhemorrhage and hemosiderin deposition around amyloid-laden vessels ⓘ
vascular fragility due to amyloid-laden vessels ⓘ
hasTypicalSequence T2*-weighted MRI ⓘ
gradient-echo MRI ⓘ
susceptibility-weighted imaging ⓘ
isPartOf amyloid-related imaging abnormalities ⓘ
isSubtypeOf cerebral microhemorrhage ⓘ
treatment-emergent imaging abnormality ⓘ
managementIncludes dose reduction of anti-amyloid therapy ⓘ
permanent discontinuation of anti-amyloid therapy in severe cases ⓘ
temporary interruption of anti-amyloid therapy ⓘ
monitoredBy serial brain MRI ⓘ
occursIn cerebellum ⓘ
cerebral cortex ⓘ
leptomeninges ⓘ
subcortical white matter ⓘ
requiresDifferentialDiagnosisWith cerebral amyloid angiopathy without treatment ⓘ
hypertensive microbleeds ⓘ
other causes of cerebral microhemorrhages ⓘ
riskFactor APOE ε4 allele ⓘ
advanced age ⓘ
higher doses of anti-amyloid antibodies ⓘ
pre-existing cerebral microbleeds ⓘ
temporalRelationToTreatment treatment-emergent during anti-amyloid therapy ⓘ

How these facts were elicited

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.

Leqembi → hasCommonAdverseEffect → ARIA-H (amyloid-related imaging abnormalities with microhemorrhages and hemosiderin deposits) ⓘ